Diagnosis and Management of Hematological Adverse Events Induced by Immune Checkpoint Inhibitors: A Systematic Review

Frontiers in Immunology
Nabil E OmarSaid Dermime

Abstract

There has been less volume of literature focusing on the Immune-related Hematological Adverse Drug Events (Hem-irAEs) of Immune Checkpoint Inhibitors (ICPis) in cancer patients. Furthermore, there has been no consensus about the management of hematological toxicity from immunotherapy in the recently published practice guidelines by the European Society for Medical Oncology (ESMO). We conducted a systematic review of case reports/series to describe the diagnosis and management of potentially rare and unrecognized Hem-irAEs. We searched Medline, OVID, Web of Science for eligible articles. Data were extracted on patient characteristics, Hem-irAEs, and management strategies. We performed quality assessment using the Pierson-5 evaluation scheme and causality assessment using the Naranjo scale. Our search retrieved 49 articles that described 118 cases. The majority of patients had melanoma (57.6%) and lung cancer (26.3%). The most common Hem-irAEs reported with ICPis (such as nivolumab, ipilimumab, and pembrolizumab) were thrombocytopenia, hemolytic and aplastic anemias. Less reported adverse events included agranulocytosis and neutropenia. Steroids were commonly used to treat these adverse events with frequent success. Other used st...Continue Reading

References

Aug 1, 1981·Clinical Pharmacology and Therapeutics·C A NaranjoD J Greenblatt
Sep 27, 2000·Journal of Clinical Epidemiology·D MoherA Liberati
Dec 5, 2008·Cancer Immunology, Immunotherapy : CII·Ilyssa O GordonThomas F Gajewski
Feb 27, 2009·Journal of Immunotherapy·Mojtaba AkhtariMartha L Arellano
Aug 3, 2011·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·S AhmadM Iddawela
Dec 24, 2011·Nature·Ira MellmanGlenn Dranoff
Jan 20, 2012·The New England Journal of Medicine·Jay Lozier
Dec 6, 2012·Experimental Hematology & Oncology·Guoqing WeiDelong Liu
Jun 10, 2014·Journal of Immunotherapy·Pauline du RusquecBrigitte Dréno
Jul 6, 2014·Journal of Medical Case Reports·Ester SimeonePaolo Antonio Ascierto
Jan 15, 2015·Japanese Journal of Clinical Oncology·Jindřich KopeckýOtakar Kopecký
Mar 21, 2015·Oncology Research and Treatment·Sebastian WoźniakJacek Mackiewicz
Jun 21, 2015·Trends in Molecular Medicine·Yago Pico de CoañaRolf Kiessling
Jun 30, 2015·Translational Research : the Journal of Laboratory and Clinical Medicine·Shannon K QuirkDevendra K Agrawal
Nov 26, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S KanameishiK Kabashima
Dec 22, 2015·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Audrey Le RoyOlivier Lambotte
Dec 31, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S ChampiatA Marabelle
Jan 23, 2016·Melanoma Research·Benjamin Y KongMatteo S Carlino
Mar 18, 2016·The New England Journal of Medicine·Ranjit NairSuresh G Nair
Aug 28, 2016·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Samer TabchiNormand Blais
Aug 30, 2016·Journal of Investigative Medicine High Impact Case Reports·Makiko Ban-HoefenDeepak Sahasrabudhe
Dec 7, 2016·Case Reports in Oncology·Amruth R PallaDonald Doll
Jan 4, 2017·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M TakeshitaK Inoue
Feb 28, 2017·Journal for Immunotherapy of Cancer·Eileen ShiuanDouglas Johnson
Feb 28, 2017·Journal for Immunotherapy of Cancer·Uqba KhanTarik Hadid
Apr 4, 2017·Annals of Oncology : Official Journal of the European Society for Medical Oncology·D ShahH Saeed
Apr 14, 2017·Annals of Oncology : Official Journal of the European Society for Medical Oncology·H HelgadottirG Masucci
May 21, 2017·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Jean-Marie MichotOlivier Lambotte
Jun 19, 2017·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Alice Bernard-TessierJean-Marie Michot
Jul 27, 2017·The Permanente Journal·Dinesh AtwalFade Mahmoud
Aug 22, 2017·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Rachel R ComitoNicholas Forcello
Sep 6, 2017·Melanoma Research·Akihiko YukiTakuro Ishiguro
Sep 28, 2017·Oncology Research and Treatment·Yusuf KarakasSaadettin Kılıckap
Nov 8, 2017·Journal of Immunotherapy·Yamin SunCristhiam M Rojas-Hernandez
Jan 19, 2018·Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur̈ Transfusionsmedizin Und Immunham̈atologie·Claudia PföhlerThomas Vogt
Apr 17, 2018·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Kentaro TokumoNoboru Hattori

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
Biopsy

Software Mentioned

PRISMA

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Related Papers

Asia-Pacific Journal of Clinical Oncology
Rongrong HuXuemei Li
Critical Reviews in Oncology/hematology
Takeo FujiiJoud Hajjar
© 2021 Meta ULC. All rights reserved